Financial Performance Analysis Of Pharmaceutical Companies Before And After The Implementation of BPJS Kesehatan Program During The Period of 2010-2017

About Us

Ipmi Repository is an online archive service which is managed by IPMI Library - Learning Resource Center. Established for collecting, managing, saving, preserving and disseminating digital copies of intellectual output of IPMI International Business School such as academic journal, books, theses, Group Field Project, Community Involvement Project, Case Study, conference paper, and other types of research publication. The main objective of this repository is to provide long-term, public, open access and easily retrieve to the digital collection to support teaching-learning process.

"Knowledge without observation is nil"

Daryanto, Candraditia (2019) Financial Performance Analysis Of Pharmaceutical Companies Before And After The Implementation of BPJS Kesehatan Program During The Period of 2010-2017. Graduate thesis, Sekolah Tinggi Manajemen IPMI.

[img] Text
Restricted to Registered users only

Download (3MB)


The Government of Indonesia started to implement the National Health Insurance or Jaminan Kesehatan Nasional (JKN) program on 1st January, 2014 through its Social Insurance Administration Body or BPJS Kesehatan. This program was providing health care and social insurance, including monitoring and controlling the prescriptive drug and medicine cost in Indonesia by recommending the pharmaceutical companies to produce and sell generic drugs which has a relatively low price. Generic drugs were recommended as an alternative to the high price of medicines while ninety percent of the raw materials of drugs were still dependent on imports. This study aims to analyze the financial health condition before and after the implementation of BPJS Kesehatan Program of two pharmaceutical SOEs; 1) Kimia Farma; 2) Indofarma; and two private companies; 1) Kalbe Farma; 2) Darya Varia. The results of investigating the financial ratios which collected from the audited financial reports, then be validated by the decree to conclude the financial health condition of them. The significant differences will also be calculated using statistical method of paired t-test between the period of before the implementation in 2010-2013 and after the implementation in 2014-2017. The study result showed that there was a declining tendency in general from all of the calculated value of the companies, especially for state owned companies. Indofarma’s performance from before and after period was worsened and the lowest in comparison with Kimia Farma where it was overall showing a steady health performance with only minor decline. The calculation result from paired samples t-test are proving the significant differences between two samples of before and after the implementation of BPJS Kesehatan Program with varied result from each company depends on the calculation of the financial ratios. Kimia Farma have the most significant differences in financial performances, specifically in Return on Investment, Inventory Turnover and Total Asset Turnover. On the contrary, Indofarma did not show any significant differences at all to its financial performance. The private companies also showed a significant difference in their Return on Equity. Password: Financial Performance, Financial Ratio, Paired t-test, Pharmaceutical Industry

Item Type: Thesis (Graduate)
Subjects: H Social Sciences > HC Economic History and Conditions
H Social Sciences > HG Finance
Divisions: Thesis > Master of Business Administration
Depositing User: Hasna Salsabila
Date Deposited: 17 Jan 2020 03:09
Last Modified: 17 Jan 2020 03:09

Actions (login required)

View Item View Item